Skip to main content

8 Result(s)

within Ashish Kalra Remove this filter

and

  1. No Access

    Article

    How Ethical Leadership and Ethical Self-Leadership Enhance the Effects of Idiosyncratic Deals on Salesperson Work Engagement and Performance

    To meet the shifting needs and preferences of the contemporary sales workforce, sales organizations are deploying idiosyncratic deals (I-deals), or mutually beneficial individualized workplace arrangements bet...

    Ashish Kalra, Rakesh Singh, Vishag Badrinarayanan… in Journal of Business Ethics (2024)

  2. No Access

    Article

    “A little competition goes a long way”: Substitutive effects of emotional intelligence and workplace competition on salesperson creative selling

    Despite receiving significant attention in the popular press, the topic of creative selling remains underexamined in the sales literature. The current research helps to correct this notable omission by explori...

    Ashish Kalra, Riley Dugan, Raj Agnihotri in Marketing Letters (2022)

  3. No Access

    Chapter and Conference Paper

    Towards Abundant Sales Organizations: How Workplace Spirituality and Innovative Climate Foster Customer-Related Outcomes: An Abstract

    Firms are rapidly acknowledging that employees seek meaning and purpose at work by develo** a positive and nurturing work environment as well as a supportive organizational climate. Ulrich and Ulrich (2010) ...

    Ashish Kalra, Vishag Badrinarayanan… in From Micro to Macro: Dealing with Uncertai… (2022)

  4. Article

    Open Access

    A Randomized Phase 1 Safety, Pharmacokinetic and Pharmacodynamic Study of the Novel Myostatin Inhibitor Apitegromab (SRK-015): A Potential Treatment for Spinal Muscular Atrophy

    Apitegromab (SRK-015) is an anti-promyostatin monoclonal antibody under development to improve motor function in patients with spinal muscular atrophy, a rare neuromuscular disease. This phase 1 double-blind, ...

    Doreen Barrett, Sanela Bilic, Yung Chyung, Shaun M. Cote… in Advances in Therapy (2021)

    Download PDF (788 KB) View Article

  5. Article

    Open Access

    Systems biology driving drug development: from design to the clinical testing of the anti-ErbB3 antibody seribantumab (MM-121)

    The ErbB family of receptor tyrosine kinases comprises four members: epidermal growth factor receptor (EGFR/ErbB1), human EGFR 2 (HER2/ErbB2), ErbB3/HER3, and ErbB4/HER4. The first two members of this family, ...

    Birgit Schoeberl, Art Kudla, Kristina Masson… in npj Systems Biology and Applications (2017)

    Download PDF (3642 KB) View Article

  6. No Access

    Reference Work Entry In depth

    HER3

    ErbB3/HER3 belongs to the family of ErbB receptors, which comprises  four transmembrane receptors that can bind more than ten different ligands. The ErbB3 receptor forms heterodimers with the other ErbB recept...

    Alexey Lugovskoy, Michael Curley, Johanna Lahdenranta… in Cancer Therapeutic Targets (2017)

  7. No Access

    Living Reference Work Entry In depth

    HER3

    ErbB3/HER3 belongs to the family of ErbB receptors, which comprises  four transmembrane receptors that can bind more than ten different ligands. The ErbB3 receptor forms heterodimers with the other ErbB recept...

    Alexey Lugovskoy, Michael Curley, Johanna Lahdenranta… in Cancer Therapeutic Targets

  8. No Access

    Article

    Development and Characterization of Nanostructured Mists with Potential for Actively Targeting Poorly Water-Soluble Compounds into the Lungs

    To formulate nanoemulsions (NE) with potential for delivering poorly water-soluble drugs to the lungs.

    Jerry Nesamony, Ashish Kalra, Mohamed S. Majrad… in Pharmaceutical Research (2013)